EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.

1. 11.

   Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers · 2006

2. 27.

   Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma · 2011

3. 36.

   Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor · 2011

37 more references, whose wording the paper’s licence keeps private.

• Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years? · 2020

• Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy · 2019

• Biology and clinical relevance of EpCAM · 2019

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.